One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
What Is Chromosome Karyotype Analysis?April 4, 2023Chromosome karyotype analysis is a technique that traditionally involves observing the morphology of chromosomes. In recent years, fluorescence in situ hybridization technology has been used to detect...view
Advantages of NGS Genetic TestingApril 16, 2025What is NGS Genetic Testing?Genes are sequences that store all the genetic information of life. Gene sequences are primarily inherited from parents, but genes in different cells can also mutate. Nobel...view
Introduction to Microarray Chip Analysis TechnologyApril 10, 2024Microarray chip analysis technology, as an important innovation in the field of modern biotechnology, plays an increasingly important role in the fields of genomics, proteomics, and disease diagnosis ...view